The board of directors of Pfizer Inc (NYSE:PFE) declared on Thursday its dividend of USD0.34 on its common stock for the Q4 2018.
Shareholders of record at the close of business on 9 November 2018 will receive the dividend payment on 3 December 2018.
In addition, the cash dividend will be the company's 320th consecutive quarterly dividend.
According to the company, it is engaged in the discovery, development and manufacture of health care products, including medicines and vaccines as well as many of the world's best-known consumer health care products.
Bruker Corporation to acquire ELITechGroup for EUR870m, strengthening MDx portfolio
Perrigo announces quarterly dividend increase
Bruker expands Preclinical Imaging Portfolio with acquisition of Spectral Instruments Imaging
Fusion Antibodies announces receipt of follow-on project and provides R&D update
Alvotech reports positive results for AVT03, potential biosimilar to Prolia and Xgeva
Biosenic finalises agreement with Phebra for oral arsenic troxide development